DR LAL PATHLABS
|
|
BOM : 539524     NSE : LALPATHLAB     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Apr 29,2024 |
Price(EOD): ₹ 2,348.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 19,612.90 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DR LAL PATHLABS | 4.5% | 3.6% | 23.6% |
APOLLO HOSPITALS ENTERPRISE | -3.6% | -5.6% | 41.6% |
MAX HEALTHCARE INSTITUTE | 10.2% | 8% | 82.4% |
GLOBAL HEALTH | 4% | 12.9% | 195.1% |
FORTIS HEALTHCARE | -0.8% | 7.8% | 67.8% |
NARAYANA HRUDAYALAYA | 1.2% | 1.3% | 67.7% |
ASTER DM HEALTHCARE | -10.9% | -18.5% | 41% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 1.5% | -1% | 31.3% |
RAINBOW CHILDRENS MEDICARE | 1.3% | 8.2% | 73.2% |
FUNDAMENTAL ANALYSIS OF DR LAL PATHLABS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DR LAL PATHLABS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
58.81
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 333.40 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] 12.19
P/B Calculated based on Book Value of Rs 1,608.03 Cr
[Latest Year - Mar2023 - Consolidated Results ] 9.03
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,172.20 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
20% -5% -7% |
SHARE PRICE MOMENTUM OF DR LAL PATHLABS
DR LAL PATHLABS vs SENSEX
DEBT OF DR LAL PATHLABS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.15 0.24 0 0.13 |
0.15 0.24 0 0.13 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DR LAL PATHLABS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DR LAL PATHLABS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-10.38% -20.92% -23.85% -25.75% |
10.11% 24.42% 51.5% 53.36% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2023 | ||
Quarterly Result Analysis → |
DR LAL PATHLABS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 150 MIDCAP | 3.4% | 7.9% | 60% |
S&P BSE 400 MIDSMALLCAP | 3.3% | 8.8% | 61.9% |
S&P BSE MIDSMALLCAP | 3.3% | 9.3% | 67.3% |
S&P BSE SMALL CAP | 2.7% | 10.5% | 66.9% |
S&P BSE HEALTHCARE | 2.2% | 3.1% | 56.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY FREE MIDCAP 100 | 3.5% | 7.4% | 62.9% |
NIFTY MIDCAP150 | 3.4% | 7.7% | 60.6% |
NIFTY MID SMALL400 | 3.3% | 9.1% | 64.6% |
NIFTY MIDCAP150 QUALITY 50 | 2.6% | 5% | 34.1% |
NIFTY HEALTHCARE | 2.5% | 1.6% | 52.8% |
You may also like the below Video Courses
FAQ about DR LAL PATHLABS
Is DR LAL PATHLABS good for long term investment?
As on Apr 29,2024, the Fundamentals of DR LAL PATHLABS look Strong and hence it may be good for long term investment! See Financial Performance of DR LAL PATHLABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DR LAL PATHLABS UnderValued or OverValued?
As on Apr 29,2024, DR LAL PATHLABS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of DR LAL PATHLABS ?
As on Apr 29,2024, the Intrinsic Value of DR LAL PATHLABS is Rs. 2,471.54 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,959.15
Fair Value [Median EV / Sales Model] : Rs. 2,471.54
Fair Value [Median Price / Sales Model] : Rs. 2,513.01
Estimated Median Fair Value of DR LAL PATHLABS : Rs. 2,471.54
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.